Standout Papers

The diagnosis of demen... 1963 2026 1984 2005 13.3k
  1. The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease (2011)
    Guy M. McKhann, David S. Knopman et al. Alzheimer s & Dementia
  2. Kinetics of Adsorption on Carbon from Solution (1963)
    Walter J. Weber, John C. Morris Journal of the Sanitary Engineering Division
  3. The Clinical Dementia Rating (CDR) (1993)
    John C. Morris Neurology
  4. Current Concepts in Mild Cognitive Impairment (2001)
    Ronald C. Petersen, Rachelle S. Doody et al. Archives of Neurology
  5. Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory (2005)
    Randy L. Buckner, Abraham Z. Snyder et al. Journal of Neuroscience
  6. Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease (2010)
    Kwasi G. Mawuenyega, Wendy Sigurdson et al. Science
  7. Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease (1996)
    Teresa Gómez‐Isla, Joseph L. Price et al. Journal of Neuroscience
  8. Alzheimer’s Disease: The Challenge of the Second Century (2011)
    David M. Holtzman, John C. Morris et al. Science Translational Medicine
  9. Blood–brain barrier breakdown is an early biomarker of human cognitive dysfunction (2019)
    Daniel A. Nation, Melanie D. Sweeney et al. Nature Medicine
  10. Open Access Series of Imaging Studies (OASIS): Cross-sectional MRI Data in Young, Middle Aged, Nondemented, and Demented Older Adults (2007)
    Daniel S. Marcus, Tracy H. Wang et al. Journal of Cognitive Neuroscience
  11. A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: reliability and validation against manual measurement of total intracranial volume (2004)
    Randy L. Buckner, Denise Head et al. NeuroImage
  12. Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. (1988)
    John C. Morris, Richard C. Mohs et al. PubMed
  13. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ 42 in humans (2005)
    Anne M. Fagan, Mark A. Mintun et al. Annals of Neurology
  14. Human apoE Isoforms Differentially Regulate Brain Amyloid-β Peptide Clearance (2011)
    Joseph M. Castellano, Jungsu Kim et al. Science Translational Medicine
  15. [ 11 C]PIB in a nondemented population (2006)
    Mark A. Mintun, Gina LaRossa et al. Neurology
  16. The Acid Ionization Constant of HOCl from 5 to 35° (1966)
    John C. Morris The Journal of Physical Chemistry
  17. The AD8 (2005)
    James E. Galvin, Catherine M. Roe et al. Neurology
  18. The Uniform Data Set (UDS): Clinical and Cognitive Variables and Descriptive Data From Alzheimer Disease Centers (2006)
    John C. Morris, Sandra Weıntraub et al. Alzheimer Disease & Associated Disorders
  19. Mild Cognitive Impairment as a Clinical Entity and Treatment Target (2005)
    Ronald C. Petersen, John C. Morris Archives of Neurology
  20. The Alzheimer's Disease Centers' Uniform Data Set (UDS) (2009)
    Sandra Weıntraub, David P. Salmon et al. Alzheimer Disease & Associated Disorders
  21. Cerebrospinal Fluid tau/β-Amyloid42 Ratio as a Prediction of Cognitive Decline in Nondemented Older Adults (2007)
    Anne M. Fagan, Catherine M. Roe et al. Archives of Neurology
  22. The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception (2013)
    Michael W. Weiner, Dallas P. Veitch et al. Alzheimer s & Dementia
  23. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease (1991)
    Joseph L. Price, Paula B. Davis et al. Neurobiology of Aging
  24. APOE predicts amyloid‐beta but not tau Alzheimer pathology in cognitively normal aging (2009)
    John C. Morris, Catherine M. Roe et al. Annals of Neurology
  25. Under-Recruitment and Nonselective Recruitment (2002)
    Jessica M. Logan, Abraham Z. Snyder et al. Neuron
  26. The National Alzheimer's Coordinating Center (NACC) Database: The Uniform Data Set (2007)
    Duane Beekly, Erin M. Ramos et al. Alzheimer Disease & Associated Disorders
  27. Functional deactivations: Change with age and dementia of the Alzheimer type (2003)
    Cindy Lustig, Abraham Z. Snyder et al. Proceedings of the National Academy of Sciences
  28. Altered expression of synaptic proteins occurs early during progression of Alzheimer’s disease (2001)
    Eliezer Masliah, Margaret Mallory et al. Neurology
  29. Clinicopathologic Studies in Cognitively Healthy Aging and Alzheimer Disease (1998)
    Daniel W. McKeel, J. Philip Miller et al. Archives of Neurology
  30. Validity and Reliability of the Alzheimerʼs Disease Cooperative Study-Clinical Global Impression of Change (1997)
    Lara Schneider, Jason T. Olin et al. Alzheimer Disease & Associated Disorders
  31. High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis (2019)
    Suzanne E. Schindler, James G. Bollinger et al. Neurology
  32. Tau and Aβ imaging, CSF measures, and cognition in Alzheimer’s disease (2016)
    Matthew R. Brier, Brian A. Gordon et al. Science Translational Medicine
  33. Sleep Quality and Preclinical Alzheimer Disease (2013)
    Yo‐El S. Ju, Jennifer McLeland et al. JAMA Neurology
  34. Kinetics of oxidation of aqueous sulfide by oxygen (1972)
    Kenneth Y. Chen, John C. Morris Environmental Science & Technology
  35. Loss of Intranetwork and Internetwork Resting State Functional Connections with Alzheimer's Disease Progression (2012)
    Matthew R. Brier, John B. Thomas et al. Journal of Neuroscience
  36. Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study (2013)
    Stephanie J. B. Vos, Chengjie Xiong et al. The Lancet Neurology
  37. Amyloid β concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis (2017)
    Vitaliy Ovod, Kwasi G. Mawuenyega et al. Alzheimer s & Dementia
  38. Version 3 of the Alzheimer Disease Centers’ Neuropsychological Test Battery in the Uniform Data Set (UDS) (2017)
    Sandra Weıntraub, Lilah M. Besser et al. Alzheimer Disease & Associated Disorders
  39. On the path to 2025: understanding the Alzheimer’s disease continuum (2017)
    Paul Aisen, Jeffrey L. Cummings et al. Alzheimer s Research & Therapy
  40. Drug development in Alzheimer’s disease: the path to 2025 (2016)
    Jeffrey L. Cummings, Paul Aisen et al. Alzheimer s Research & Therapy
  41. Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative (2018)
    Dallas P. Veitch, Michael W. Weiner et al. Alzheimer s & Dementia
  42. Circadian Rest-Activity Pattern Changes in Aging and Preclinical Alzheimer Disease (2018)
    Erik S. Musiek, John C. Morris et al. JAMA Neurology
  43. Gut microbiome composition may be an indicator of preclinical Alzheimer’s disease (2023)
    Aura Ferreiro, JooHee Choi et al. Science Translational Medicine
  44. Disease staging of Alzheimer’s disease using a CSF-based biomarker model (2024)
    Gemma Salvadó, Kanta Horie et al. Nature Aging
  45. Plasma MTBR-tau243 biomarker identifies tau tangle pathology in Alzheimer’s disease (2025)
    Kanta Horie, Gemma Salvadó et al. Nature Medicine

Immediate Impact

6 by Nobel laureates 53 from Science/Nature 301 standout
Sub-graph 1 of 15

Citing Papers

Single-cell multiregion dissection of Alzheimer’s disease
2024 StandoutNature
Lecanemab in Early Alzheimer’s Disease
2022 Standout
125 intermediate papers

Works of John C. Morris being referenced

The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
2011 Standout
The Clinical Dementia Rating (CDR)
1993 Standout
and 79 more

Author Peers

Author Last Decade Papers Cites
John C. Morris 46867 43206 24123 986 112.4k
Albert Hofman 16683 16884 5001 1.5k 118.0k
Philip Scheltens 42680 35634 29096 1.2k 97.2k
Bengt Winblad 22729 27211 7557 1.2k 77.3k
Monique M.B. Breteler 15543 15321 4285 478 64.6k
David A. Bennett 27738 31644 9736 1.3k 82.7k
Clifford R. Jack 52132 44990 29145 1.1k 101.3k
David S. Knopman 46210 39897 22491 986 90.7k
Guy M. McKhann 26110 22361 13797 440 66.0k
Paul M. Thompson 22021 15918 32896 1.9k 109.2k
Ronald C. Petersen 59507 50178 28644 1.1k 112.7k

All Works

Loading papers...

Rankless by CCL
2026